PAVmed Receives FDA 510(k) Clearance for its CarpX™ Minimally Invasive Carpal Tunnel Device
21 avr. 2020 09h30 HE
|
PAVmed Inc.
NEW YORK, April 21, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced it has...
PAVmed Receives Formal Notification of Nasdaq Continued Listing Compliance
13 janv. 2020 09h30 HE
|
PAVmed Inc.
NEW YORK, Jan. 13, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced it has...
PAVmed Provides Update on CarpX™ Clinical Safety Study
13 déc. 2019 09h30 HE
|
PAVmed Inc.
NEW YORK, Dec. 13, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today provided an update on...
PAVmed Secures Financing up to $14 Million for Advancement of its Lead Products to Commercialization
05 nov. 2019 07h00 HE
|
PAVmed Inc.
Extends cash runway to support multiple milestones including commercialization of two lead products NEW YORK, Nov. 05, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or...
PAVmed Subsidiary Lucid Diagnostics Receives FDA 510(k) Clearance for EsoCheck™
24 juin 2019 10h46 HE
|
PAVmed Inc.
NEW YORK, June 24, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product medical device company, today announced that its...
PAVmed Provides Business Update
17 oct. 2018 07h30 HE
|
PAVmed Inc.
NEW YORK, Oct. 17, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today provided an update on...
PAVmed Reports Second Quarter 2018 Financial Results and Provides Business Update
14 août 2018 07h30 HE
|
PAVmed Inc.
Conference call to be held August 22, 2018 at 4:30 p.m. Eastern time NEW YORK, Aug. 14, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly...